Drug Information Association Logo
Corporate Tagline

EDC Insights: Before, During, and After

Track:
Processes and Technologies for Clinical Research

Day & Time:
June 26, 10:15AM - 11:45AM

Session Number:
334

Room Number:
251

Level:
Intermediate

Type:
Symposium

Title:
EDC Insights: Before, During, and After

Chair(s):
Maryanne C. Nicosia, MS
Director, Clinical Data Management
Neurocrine Biosciences Inc., United States

Description:
This symposium will provide multiple perspectives on selecting, implementing, and getting the most out of an EDC system. Insight will be provided on the factors to consider and the critical questions to ask in order to choose the best EDC platform for an organization or clinical study. Attendees will also learn to determine which EDC-related challenges can be fixed through process re-engineering and change management, which issues truly necessitate switching to a new system, and the challenges and costs associated with moving to a new system. Finally, attendees will hear about current trends for using alternative EDC solutions in postmarketing studies.

Learning Objective(s):
Discuss the importance of ensuring optimum efficiency gains from selecting an EDC system; Define a list of questions (quantitative framework) that can be used to assist in EDC system selection; Evaluate ROI from choosing the appropriate EDC system; Explain the quantitative and qualitative costs of switching EDC platforms; Identify the most common EDC challenges and cost-effective solutions; Discuss trends in conducting postmarketing trials using EDC, focusing on changing needs/priorities.

Presentation(s) & Speaker(s):
Love the One You're With: The High Costs of Switching EDC Platforms and How to Get the Most Out of Your Current One
Kent Mahoney, MBA
Director
Soltex Consulting LLP, United States

Electronic Data Capture: The Importance and Impact of Selecting the Optimum EDC Platform for Your Clinical Program
Toby Odenheim, MBA
Director, IT Services
SynteractHCR, United States

© 2013 DIA